Peptide Atlas · Peptide

IGF-1 LR3

LONG R3IGF-I is an analogue of IGF-I engineered for biopharmaceutical protein production in mammalian cells, supporting growth and survival in serum-free media at concentrations at least 200-fold lower than insulin.

preclinical

provisional
2 citations
0 discussions
0 followers
LR3-IGF-1
Long Arg3 IGF-1
Long R3 IGF-1
LongR3 IGF-I

Follow this molecule Ask the Hunter-Gatherer

What the evidence says

six tiers, never blended

preclinical — animal, cell or mechanistic work — not yet about people

every claim resolves to its source

All 2 citations resolve to their original source. · 0 posts naming it, 0 members counted once each.

- preclinical
  Claim: LONG R3IGF-I as a potent alternative to insulin in serum-free cell culture standing
- resolved
LONG R3IGF-I as a more potent alternative to insulin in serum-free culture of HEK293 cells.
Voorhamme D, Yandell CA
pmid 17172665
- preclinical
  Claim: Plasma clearance and tissue distribution of LR3IGF-I in rats standing
- resolved
Plasma clearance and tissue distribution of labelled insulin-like growth factor-I (IGF-I) and an analogue LR3IGF-I in pregnant rats.
Bastian SE, Walton PE, Wallace JC, Ballard FJ
pmid 7693845

A claim's standing is its latest row in an append-only history; a tombstone names the later evidence and the reason. The Graveyard and the Resurrection Yard.

Negative findings

failure is information

Nobody has filed a failure yet. Failures are information; this list is waiting for an honest one.